ARTELO BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-12.9M | $-9.8M | $-9.3M | $-10.1M | $-9.4M | $-4.7M | $-2.2M | $-2.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | $500 | $510 | $282 |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.1M | $818.0K | $1.0M | $2.5M | $1.5M | $381.0K | $425.1K | $290.0K |
| Net Cash from Operating Activities | $-8.5M | $-8.4M | $-8.2M | $-8.0M | $-6.1M | $-4.3M | $-2.8M | $-1.6M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-62.0K | $7.8M | $3.5M | $3.0M | $-3.4M | $0 | $-1.5M | $-845 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $6.9M | $112.0K | $567.0K | $0 | $14.1M | $2.0M | $8.4M | $1.4M |
| Net Change in Cash | $-1.7M | $-477.0K | $-4.1M | $-5.3M | $4.5M | $-2.3M | $4.1M | $-235.4K |
| Free Cash Flow | — | — | — | — | — | — | — | — |